"
Team:Waterloo
From 2014.igem.org
(Difference between revisions)
m |
m |
||
| Line 18: | Line 18: | ||
<div class="tabcontents"> | <div class="tabcontents"> | ||
<div class="anchor" id="view0" style="padding-top:0px;"> | <div class="anchor" id="view0" style="padding-top:0px;"> | ||
| - | <div style="padding-bottom:50px; min-height: 200px; margin-bottom: | + | <div style="padding-bottom:50px; min-height: 200px; margin-bottom: 40px;"> |
<div class="half-column floatLeft"> | <div class="half-column floatLeft"> | ||
<h2 class="centerUpper blueOnGrey">Problem</h2> | <h2 class="centerUpper blueOnGrey">Problem</h2> | ||
Revision as of 23:45, 17 October 2014
Staphylocide
Delivering Antibiotic Resistance Gene Silencing Mechanism to a MRSA Population using Bacterial Conjugation
Problem
MRSA is sweeping the nation, an antibiotic-resistant scourge migrating from hospitals into communities. We need a hero to fight it and Waterloo iGEM has designed a synthetic bacterium that just might do the trick...
Solution
...Staphylocide! Staphylocide delivers antibiotic resistance gene silencing in vivo and could one day be incorporated into a treatment that would help doctors defeat MRSA once and for all.
Project Cornerstones
Explore the three cornerstones of this year's project: delivering the silencing in vivo using conjugation, silencing mecA expression using CRISPRi and sRNA and translating from the lab to the patients.
